Effective for dates of service on or after November 6, 2022, AIM Specialty Health® (AIM) has revised their Advanced Imaging Clinical Appropriateness Guidelines for Diagnostic Coronary Angiography for AmeriHealth HMO, Inc., AmeriHealth Insurance Company of New Jersey, and AmeriHealth Administrators Commercial members. For full details, view the specific guidelines.
For more information on AIM's revised Advanced Imaging Clinical Appropriateness Guidelines for Diagnostic Coronary Angiography, please refer to Commercial policy #11.02.27f: Percutaneous Coronary Intervention, Coronary Angiography and Arterial Ultrasound on our Medical and Claim Payment Policy Portal, which will be published on December 5, 2022.